PARIS and AACHEN, Germany, June 13 /PRNewswire/ -- Results from two phase III clinical studies of tapentadol immediate release tablets (IR) suggest a significantly improved gastrointestinal tolerability(1) as well as safety(2) profile compared to oxycodone HCl IR. The data were presented by the German pharmaceutical company Grunenthal at this year's Annual Congress of the European League against Rheumatism (EULAR, June 11-14, Paris, France).

LONDON, June 13 /PRNewswire/ -- Solcara, the market-leading provider of software for the control, management and searching of digital information, has announced the appointment of three senior sales managers for Financial Services, Legal & Professional Services and the Commercial Sector.

Commenting on the expansion of Solcara's sales force Rob Martin, Managing Director, said:

"Solcara has reached a stage in its development where we are confident in accelerating our growth plans and extending our client base in these critical business sectors. Through senior hires, new product development, and the growth of our channel sales partnership, we are taking the necessary steps to consolidate and strengthen our leadership position."

The appointments are:

Today Doritos makes history, taking the UK’s first step in communicating with aliens as they broadcast the first ever advert directed towards potential extra terrestrial life.

The transmission is being undertaken as part of the Doritos Broadcast Project, which invited the UK public to create a 30 second video clip that could be beamed out to the universe offering a snap shot of life on earth to anyone ‘out there’.

61% of the UK public believe this is just the start of communication with ET life and that we will enter into regular communication with an alien species at some stage in the future.

The winning space-ad entitled ‘Tribe’ was voted for by the British public and directed by 25-year-old Matt Bowron. It will officially be entered into the Guinness Book of Records and will be aired on the more conventional medium of television on Sunday 15th June on ITV at 7.44pm in the ad break of the final Group B game of Euro 2008.

MÉRIGNAC, France, June 13 /PRNewswire/ --

- Cortix: A new European Wave This Summer (June-July)

- Creation of New HQs in Dublin (Ireland) and Milan (Italy) and a new Agency in Palma, Majorca (Spain - Balearic Islands)

PARIS, June 13 /PRNewswire/ --

- Rheumatoid Arthritis is the Leading Cause of Work Disability in Europe

CARLISLE, England, June 13 /PRNewswire/ --

Published today, The Pattern Recognition Theory of Humour, by Alastair Clarke, answers the eternal question about the nature of humor. Clarke explains how and why we find things funny and identifies the reason humor is common to all human societies, its fundamental role in the evolution of humans and its continuing importance in the cognitive development of infants.

Clarke explains: "For some time now it's been assumed that a global theory of humour is impossible. This theory changes thousands of years of incorrect analyses and mini-theories that have applied to only a small proportion of instances of humour. It offers a vital answer as to why humour exists in every human society."

PARIS, June 13 /PRNewswire/ --

Seven-year rheumatoid arthritis (RA) data from open-label extension studies show that treatment with Abbott's HUMIRA(R) (adalimumab) resulted in clinical remission among long-standing RA patients when used in combination with methotrexate (MTX). The percentage of patients achieving clinical remission continued to increase after two or more years of continuous treatment with combination therapy. These data were presented at the European League Against Rheumatism (EULAR) annual meeting in Paris.

PARIS, June 13 /PRNewswire/ --

Abbott announced new data from the open-label extension of the ATLAS (Adalimumab Trial Evaluating Long-Term Efficacy and Safety in AS) phase III clinical trial, which showed HUMIRA(R) (adalimumab) reduced the signs and symptoms of ankylosing spondylitis (AS) for up to three years of treatment among 74 percent of patients tested. AS is a type of arthritis that primarily causes inflammation of the spine and the spinal joints. These data were presented at the European League Against Rheumatism (EULAR) annual meeting in Paris.

AMSTERDAM, June 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that it has concluded enrollment and treated the last patient in the pivotal trial for it's lead product AMT-011 (Glybera(R)) for Hyperlipoproteinemia, a seriously debilitating and potentially lethal disease. After recent preparatory meetings with the rapporteur countries Germany and the United Kingdom of the European Medicines Agency (EMEA), AMT expects to file the Marketing Authorization Dossier with EMEA not later than the fourth quarter of 2008.

Practice makes perfect, but a question that still remains a mystery is why it is so difficult to transfer learning from a trained to an untrained task? Why are we no better at remembering faces when we have been training our memory for words? Scientists at Umeå University and Karolinska Institutet in Sweden now show in the journal Science that the answer lies in the brain areas activated by each task.

The scientists studied the brain activity of healthy subjects as they performed a task that was part of a training program and two untrained tasks. Their performance on the trained task and one of the untrained tasks improved. What these two tasks had in common was the activation of the striatum, a cluster of neuronal nuclei in midbrain.